Literature DB >> 31883930

Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort.

Jerome H Taylor1, Nana Asabere2, Monica E Calkins2, Tyler M Moore2, Sunny X Tang2, Rose Mary Xavier3, Alison K Merikangas4, Daniel H Wolf2, Laura Almasy5, Ruben C Gur2, Raquel E Gur2.   

Abstract

Little is known about the impact of family history of psychosis on youth from community samples. To fill this gap, we compared youth with a first-degree relative with psychosis spectrum symptoms (i.e. family history of psychosis spectrum symptoms, FHPS) to youth without FHPS in a cross-sectional analysis of the Philadelphia Neurodevelopmental Cohort (PNC). The PNC is a racially diverse community sample of 9498 youth ages 8-21 years old, of whom 8928 completed the Family Interview for Genetic Studies to determine FHPS status. Polygenic risk score for schizophrenia (PRSS) was available for a subsample of 4433 European Americans. FHPS youth (n = 489) constituted 5.5% of the analytic sample. After adjusting for environmental risk factors (sociodemographic variables and traumatic stressful events), FHPS youth had lower functioning on the Children's Global Assessment Scale and elevated psychosis spectrum, mood, externalizing, and fear symptoms compared to non-FHPS youth (all p < .001). In the European-American subsample, FHPS status was associated with poorer functioning and greater symptom burden in all four psychopathology domains (all p < .001), even after covarying for PRSS. Thus, ascertaining FHPS is important because it is uniquely associated with symptoms and functional impairment in community youth beyond PRS-S and the environmental risk factors we investigated. Future research identifying environmental causes of FHPS-associated impairment could inform the development of interventions for the broad array of symptoms observed in FHPS youth.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescents; Children; Cognition; Familial high risk; Polygenic risk score; Schizophrenia

Mesh:

Year:  2019        PMID: 31883930      PMCID: PMC7239716          DOI: 10.1016/j.schres.2019.12.021

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  69 in total

1.  The psychological well-being of family members of individuals with schizophrenia.

Authors:  L Martens; J Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2001-03       Impact factor: 4.328

2.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

3.  Association between traumatic stress load, psychopathology, and cognition in the Philadelphia Neurodevelopmental Cohort.

Authors:  Ran Barzilay; Monica E Calkins; Tyler M Moore; Daniel H Wolf; Theodore D Satterthwaite; J Cobb Scott; Jason D Jones; Tami D Benton; Ruben C Gur; Raquel E Gur
Journal:  Psychol Med       Date:  2018-04-15       Impact factor: 7.723

4.  Psychometric properties of the Penn Computerized Neurocognitive Battery.

Authors:  Tyler M Moore; Steven P Reise; Raquel E Gur; Hakon Hakonarson; Ruben C Gur
Journal:  Neuropsychology       Date:  2014-09-01       Impact factor: 3.295

Review 5.  Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis.

Authors:  E Bora; A Lin; S J Wood; A R Yung; P D McGorry; C Pantelis
Journal:  Acta Psychiatr Scand       Date:  2014-03-11       Impact factor: 6.392

6.  Burden of Environmental Adversity Associated With Psychopathology, Maturation, and Brain Behavior Parameters in Youths.

Authors:  Raquel E Gur; Tyler M Moore; Adon F G Rosen; Ran Barzilay; David R Roalf; Monica E Calkins; Kosha Ruparel; J Cobb Scott; Laura Almasy; Theodore D Satterthwaite; Russell T Shinohara; Ruben C Gur
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

7.  The CCC2000 Birth Cohort Study of Register-Based Family History of Mental Disorders and Psychotic Experiences in Offspring.

Authors:  Pia Jeppesen; Janne Tidselbak Larsen; Lars Clemmensen; Anja Munkholm; Martin Kristian Rimvall; Charlotte Ulrikka Rask; Jim van Os; Liselotte Petersen; Anne Mette Skovgaard
Journal:  Schizophr Bull       Date:  2014-12-01       Impact factor: 9.306

8.  Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation.

Authors:  Rajiv Radhakrishnan; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Lotta-Katrin Pries; Maarten Bak; Jim van Os
Journal:  Psychol Med       Date:  2018-10-04       Impact factor: 7.723

9.  Common and Dissociable Mechanisms of Executive System Dysfunction Across Psychiatric Disorders in Youth.

Authors:  Sheila Shanmugan; Daniel H Wolf; Monica E Calkins; Tyler M Moore; Kosha Ruparel; Ryan D Hopson; Simon N Vandekar; David R Roalf; Mark A Elliott; Chad Jackson; Efstathios D Gennatas; Ellen Leibenluft; Daniel S Pine; Russell T Shinohara; Hakon Hakonarson; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite
Journal:  Am J Psychiatry       Date:  2016-01-22       Impact factor: 18.112

10.  Comparable family burden in families of clinical high-risk and recent-onset psychosis patients.

Authors:  Celine Wong; Larry Davidson; Thomas McGlashan; Ruth Gerson; Dolores Malaspina; Cheryl Corcoran
Journal:  Early Interv Psychiatry       Date:  2008-11       Impact factor: 2.732

View more
  7 in total

1.  Issues in Estimating Interpretable Lower Order Factors in Second-Order Hierarchical Models: Commentary on Clark et al. (2021).

Authors:  Tyler M Moore; Benjamin B Lahey
Journal:  Clin Psychol Sci       Date:  2021-08-09

2.  Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study.

Authors:  Jerome H Taylor; Scott Appel; Matthew Eli; Aaron Alexander-Bloch; Lawrence Maayan; Raquel E Gur; Michael H Bloch
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-07-01       Impact factor: 2.576

3.  Natural language processing methods are sensitive to sub-clinical linguistic differences in schizophrenia spectrum disorders.

Authors:  Reno Kriz; Sunghye Cho; Sunny X Tang; Suh Jung Park; Jenna Harowitz; Raquel E Gur; Mahendra T Bhati; Daniel H Wolf; João Sedoc; Mark Y Liberman
Journal:  NPJ Schizophr       Date:  2021-05-14

4.  Development of a probability calculator for psychosis risk in children, adolescents, and young adults.

Authors:  Tyler M Moore; Monica E Calkins; Adon F G Rosen; Ellyn R Butler; Kosha Ruparel; Paolo Fusar-Poli; Nikolaos Koutsouleris; Philip McGuire; Tyrone D Cannon; Ruben C Gur; Raquel E Gur
Journal:  Psychol Med       Date:  2021-01-12       Impact factor: 10.592

5.  Familial and socioeconomic contributions to premorbid functioning in psychosis: Impact on age at onset and treatment response.

Authors:  Alex Hatzimanolis; Pentagiotissa Stefanatou; Emmanouil Kattoulas; Irene Ralli; Stefanos Dimitrakopoulos; Stefania Foteli; Ioannis Kosteletos; Leonidas Mantonakis; Mirjana Selakovic; Rigas-Filippos Soldatos; Ilias Vlachos; Lida-Alkisti Xenaki; Nikolaos Smyrnis; Nicholas C Stefanis
Journal:  Eur Psychiatry       Date:  2020-04-29       Impact factor: 5.361

6.  Clinical and Functional Differences Between Mexican Youth at Clinical High Risk for Psychosis and With Familial High Risk.

Authors:  Lourdes Nieto; Tecelli Domínguez-Martínez; Mauricio Rosel-Vales; Ricardo Saracco-Alvarez; Cesar Celada-Borja; María Luisa Rascón-Gasca
Journal:  Front Psychol       Date:  2022-07-04

7.  Psychotic-like Experiences and Polygenic Liability in the Adolescent Brain Cognitive Development Study.

Authors:  Nicole R Karcher; Sarah E Paul; Emma C Johnson; Alexander S Hatoum; David A A Baranger; Arpana Agrawal; Wesley K Thompson; Deanna M Barch; Ryan Bogdan
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.